Yes, you are very confident with everything you post. The problem is you fail to understand my quite simple point that MSB’s treatment is not economically rational for Covid.
It is extremely expensive relative to other proven treatments. Critically, to be effective you need to be treated early. This means you need to treat people who will not become really sick or develop long Covid. Both of these classes of people are relatively rare compared to the numbers of people who are infected.
But you might be in that camp which advocates to hell with the cost. Spend a billion to save 12 lives. Well thank god for the FDA and TGA. Why not spend a billion on clean drinking water in third world countries and save 100s of thousands of lives. Oh yes, but that won’t help MSBs SP.
MSB Trading 2021 - paradigm shift, page-163
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |